Evidence map›Paper›PMID 40906620›Full record

ArticleThe American journal of case reports2025

Innovative Use of Atrial Septal Defect Occluders for Gastric Leak Management After Sleeve Gastrectomy: A Case Report.

Saud Alsairy, Nawaf N Almutairi

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Saud AlsairyDepartment of Surgery, Security Forces Hospital, Riyadh, Saudi Arabia.
Nawaf N AlmutairiDepartment of General Surgery, Security Forces Hospital, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Atrial septal defect (ASD) occluder devices present a novel approach for managing persistent gastric leaks following sleeve gastrectomy. While sleeve gastrectomy is effective, postoperative leak rates reach up to 3% in primary surgeries and exceed 10% in revisions, with management remaining complex and non-standardized. CASE REPORT This case report describes a 20-year-old Saudi woman who developed a gastric leak after laparoscopic sleeve gastrectomy. After a failed initial treatment with a self-expandable mega stent that migrated, she presented with severe symptoms and a significant sub-capsular splenic collection. Despite ultrasound-guided drainage and endoscopic interventions, leakage persisted. An ASD occluder device was deployed using endoscopic and fluoroscopic guidance following failed repairs. While post-application imaging initially showed no leaks and the patient's condition improved, she later experienced recurrent symptoms with persistent leakage. The case was ultimately resolved through a Roux-en-Y gastric bypass. CONCLUSIONS This case highlights the potential of ASD occluders in treating complex gastric leaks, particularly for patients reluctant to undergo repeated surgeries. The device's flexibility for repositioning and retrieval, combined with endoscopic compatibility, makes it a valuable tool for managing postoperative bariatric complications. While initial results are promising, further research is needed to validate this approach's efficacy and safety. Future studies should focus on larger cohorts to establish guidelines for ASD device use in gastrointestinal applications.

Indexed as

Anastomotic LeakGastrectomySeptal Occluder DeviceFemaleGastric BypassHeart Septal Defects, AtrialHumansObesity, MorbidYoung Adult

Identifiers

PMID40906620
PMCPMC12418895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.